JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knaapen, P.
Right arrow Articles by Visser, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knaapen, P.
Right arrow Articles by Visser, F. C.
Journal of Nuclear Medicine Vol. 45 No. 8 1299-1304
© 2004 by Society of Nuclear Medicine


Clinical Investigations

Perfusable Tissue Index as a Potential Marker of Fibrosis in Patients with Idiopathic Dilated Cardiomyopathy

Paul Knaapen, MD1, Ronald Boellaard, PhD2, Marco J.W. Götte, MD, PhD1, Pieter A. Dijkmans, MD1, Linda M.C. van Campen, MD1, Carel C. de Cock, MD, PhD1, Gert Luurtsema, BSc2, Cees A. Visser, MD, PhD1, Adriaan A. Lammertsma, PhD2 and Frans C. Visser, MD, PhD1

1 Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands
2 PET Center, VU University Medical Center, Amsterdam, The Netherlands

A varying degree of interstitial and perivascular fibrosis is a common finding in idiopathic dilated cardiomyopathy (DCM). The perfusable tissue index (PTI), obtained with PET, is a noninvasive tool for assessing myocardial fibrosis on a regional level. Measurements of the PTI in DCM, however, have not been performed yet. This study was undertaken to test the hypothesis that the PTI is reduced in patients with DCM. Methods: Fifteen patients with an advanced stage of DCM (New York Heart Association class III or IV and left ventricular ejection fraction [LVEF] < 35%) and 11 healthy control subjects were studied. PET was performed using H215O and C15O to obtain the perfusable tissue fraction (PTF) and the anatomic tissue fraction (ATF), respectively. Results: The PTI (=PTF/ATF) was reduced in DCM compared with control subjects (0.91 ± 0.12 vs. 1.12 ± 0.10; P < 0.01). Heterogeneity of the PTI, expressed as the coefficient of variation, was increased in DCM versus that of healthy control subjects (0.18 ± 0.07 vs. 0.13 ± 0.06; P < 0.05). There was no correlation between the PTI and echocardiographically derived LVEF in both groups. Conclusion: The PTI was reduced in patients with an advanced stage of DCM. Interstitial and perivascular fibrosis may be responsible for this reduction. Furthermore, the degree of the PTI reduction was variable in DCM patients, both on a regional level and between patients. Noninvasive assessment of fibrosis with the PTI offers the opportunity to evaluate the effects of fibrosis on regional myocardial function, correlate fibrosis with prognosis, and monitor pharmaceutical intervention.

Key Words: PET • perfusable tissue index • idiopathic dilated cardiomyopathy


Related articles in JNM:

THIS MONTH IN JNM

JNM 2004 45: 8A-9A. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Jerosch-Herold, D. C. Sheridan, J. D. Kushner, D. Nauman, D. Burgess, D. Dutton, R. Alharethi, D. Li, and R. E. Hershberger
Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1234 - H1242.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
T. H. Marwick and M. Schwaiger
The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 1: Tasks and Tools
Circ Cardiovasc Imaging, July 1, 2008; 1(1): 58 - 69.
[Full Text] [PDF]


Home page
Eur Heart JHome page
K. M. Marques, P. Knaapen, R. Boellaard, N. Westerhof, A. A. Lammertsma, C. A. Visser, and F. C. Visser
Hyperaemic microvascular resistance is not increased in viable myocardium after chronic myocardial infarction
Eur. Heart J., October 1, 2007; 28(19): 2320 - 2325.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. G. Assomull, S. K. Prasad, J. Lyne, G. Smith, E. D. Burman, M. Khan, M. N. Sheppard, P. A. Poole-Wilson, and D. J. Pennell
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
J. Am. Coll. Cardiol., November 21, 2006; 48(10): 1977 - 1985.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
P. Knaapen, M. J. W. Gotte, W. J. Paulus, J. J. M. Zwanenburg, P. A. Dijkmans, R. Boellaard, J. T. Marcus, J. W. R. Twisk, C. A. Visser, A. C. van Rossum, et al.
Does Myocardial Fibrosis Hinder Contractile Function and Perfusion in Idiopathic Dilated Cardiomyopathy? PET and MR Imaging Study.
Radiology, August 1, 2006; 240(2): 380 - 388.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. Knaapen, W. G. van Dockum, O. Bondarenko, W. E.M. Kok, M. J.W. Gotte, R. Boellaard, A. M. Beek, C. A. Visser, A. C. van Rossum, A. A. Lammertsma, et al.
Delayed Contrast Enhancement and Perfusable Tissue Index in Hypertrophic Cardiomyopathy: Comparison Between Cardiac MRI and PET
J. Nucl. Med., June 1, 2005; 46(6): 923 - 929.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.